$RLYP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Relypsa Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Relypsa Inc. Get notifications about new insider transactions in Relypsa Inc for free.
Page: < prev 1 2 3 4 5 5 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 23 2016 | RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Grant | A | 0.00 | 2,250 | 0 | 3,487 | 1.2 K to 3.5 K (+181.89 %) |
Jun 23 2016 | RLYP | Relypsa Inc | Schuetz Thomas J. | Director | Option Exercise | A | 17.00 | 4,500 | 76,500 | 4,500 | |
Jun 23 2016 | RLYP | Relypsa Inc | Schuetz Thomas J. | Director | Grant | A | 0.00 | 2,250 | 0 | 36,212 | 34 K to 36.2 K (+6.63 %) |
Jun 08 2016 | RLYP | Relypsa Inc | Torley Helen | Director | Sell | S | 19.32 | 1,013 | 19,570 | 1,237 | 2.3 K to 1.2 K (-45.02 %) |
Jun 08 2016 | RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Sell | S | 19.31 | 1,013 | 19,562 | 1,237 | 2.3 K to 1.2 K (-45.02 %) |
Jun 08 2016 | RLYP | Relypsa Inc | Hillan Kenneth J. | Director | Sell | S | 19.31 | 1,013 | 19,563 | 1,237 | 2.3 K to 1.2 K (-45.02 %) |
Jun 08 2016 | RLYP | Relypsa Inc | Butler John P. | Director | Sell | S | 19.32 | 1,013 | 19,570 | 2,849 | 3.9 K to 2.8 K (-26.23 %) |
Jun 08 2016 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Sell | S | 19.32 | 1,013 | 19,573 | 2,495 | 3.5 K to 2.5 K (-28.88 %) |
Jun 08 2016 | RLYP | Relypsa Inc | MCGIRR DAVID W J | Director | Sell | S | 19.34 | 1,013 | 19,588 | 2,729 | 3.7 K to 2.7 K (-27.07 %) |
Jun 07 2016 | RLYP | Relypsa Inc | Krasnow Ronald A. | See Remarks | Option Exercise | A | 18.87 | 5,833 | 110,069 | 5,833 | |
Jun 07 2016 | RLYP | Relypsa Inc | Krasnow Ronald A. | See Remarks | Payment of Exercise | F | 19.96 | 548 | 10,938 | 15,763 | 16.3 K to 15.8 K (-3.36 %) |
Jun 07 2016 | RLYP | Relypsa Inc | Krasnow Ronald A. | See Remarks | Grant | A | 0.00 | 1,458 | 0 | 16,311 | 14.9 K to 16.3 K (+9.82 %) |
Jun 07 2016 | RLYP | Relypsa Inc | Stahl Wilhelm | SVP, Chief Technolo ... | Option Exercise | A | 18.87 | 5,833 | 110,069 | 5,833 | |
Jun 07 2016 | RLYP | Relypsa Inc | Stahl Wilhelm | SVP, Chief Technolo ... | Payment of Exercise | F | 19.96 | 548 | 10,938 | 15,763 | 16.3 K to 15.8 K (-3.36 %) |
Jun 07 2016 | RLYP | Relypsa Inc | Stahl Wilhelm | SVP, Chief Technolo ... | Grant | A | 0.00 | 1,458 | 0 | 16,311 | 14.9 K to 16.3 K (+9.82 %) |
Jun 07 2016 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Option Exercise | A | 18.87 | 8,333 | 157,244 | 8,333 | |
Jun 07 2016 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Payment of Exercise | F | 19.96 | 783 | 15,629 | 15,050 | 15.8 K to 15.1 K (-4.95 %) |
Jun 07 2016 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Grant | A | 0.00 | 2,083 | 0 | 15,833 | 13.8 K to 15.8 K (+15.15 %) |
Jun 07 2016 | RLYP | Relypsa Inc | Harrison Stephen D | SVP & Chief Scienti ... | Option Exercise | A | 18.87 | 8,333 | 157,244 | 8,333 | |
Jun 07 2016 | RLYP | Relypsa Inc | Harrison Stephen D | SVP & Chief Scienti ... | Payment of Exercise | F | 19.96 | 783 | 15,629 | 18,549 | 19.3 K to 18.5 K (-4.05 %) |
Jun 07 2016 | RLYP | Relypsa Inc | Harrison Stephen D | SVP & Chief Scienti ... | Grant | A | 0.00 | 2,083 | 0 | 19,332 | 17.2 K to 19.3 K (+12.08 %) |
Jun 07 2016 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Option Exercise | A | 18.87 | 8,333 | 157,244 | 8,333 | |
Jun 07 2016 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Payment of Exercise | F | 19.96 | 783 | 15,629 | 22,590 | 23.4 K to 22.6 K (-3.35 %) |
Jun 07 2016 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Grant | A | 0.00 | 2,083 | 0 | 23,373 | 21.3 K to 23.4 K (+9.78 %) |
Jun 07 2016 | RLYP | Relypsa Inc | Corbett Mary | Senior VP, Human Re ... | Option Exercise | A | 18.87 | 5,833 | 110,069 | 5,833 | |
Jun 07 2016 | RLYP | Relypsa Inc | Corbett Mary | Senior VP, Human Re ... | Payment of Exercise | F | 19.96 | 548 | 10,938 | 18,364 | 18.9 K to 18.4 K (-2.90 %) |
Jun 07 2016 | RLYP | Relypsa Inc | Corbett Mary | Senior VP, Human Re ... | Grant | A | 0.00 | 1,458 | 0 | 18,912 | 17.5 K to 18.9 K (+8.35 %) |
Jun 07 2016 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Option Exercise | A | 18.87 | 22,500 | 424,575 | 22,500 | |
Jun 07 2016 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Payment of Exercise | F | 19.96 | 2,114 | 42,195 | 57,886 | 60 K to 57.9 K (-3.52 %) |
Jun 07 2016 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Grant | A | 0.00 | 5,625 | 0 | 60,000 | 54.4 K to 60 K (+10.34 %) |
Jun 07 2016 | RLYP | Relypsa Inc | BALL KRISTINE M | Chief Financial Off ... | Option Exercise | A | 18.87 | 8,333 | 157,244 | 8,333 | |
Jun 07 2016 | RLYP | Relypsa Inc | BALL KRISTINE M | Chief Financial Off ... | Payment of Exercise | F | 19.96 | 783 | 15,629 | 29,590 | 30.4 K to 29.6 K (-2.58 %) |
Jun 07 2016 | RLYP | Relypsa Inc | BALL KRISTINE M | Chief Financial Off ... | Grant | A | 0.00 | 2,083 | 0 | 30,373 | 28.3 K to 30.4 K (+7.36 %) |
Mar 16 2016 | RLYP | Relypsa Inc | Harrison Stephen D | SVP & Chief Scienti ... | Grant | A | 11.27 | 2,218 | 24,999 | 17,249 | 15 K to 17.2 K (+14.76 %) |
Mar 16 2016 | RLYP | Relypsa Inc | Corbett Mary | Senior VP, Human Re ... | Grant | A | 11.27 | 1,274 | 14,359 | 17,454 | 16.2 K to 17.5 K (+7.87 %) |
Mar 16 2016 | RLYP | Relypsa Inc | BALL KRISTINE M | Chief Financial Off ... | Buy | P | 12.15 | 7,000 | 85,050 | 28,290 | 21.3 K to 28.3 K (+32.88 %) |
Mar 16 2016 | RLYP | Relypsa Inc | Schuetz Thomas J. | Director | Buy | P | 13.39 | 30,000 | 401,832 | 33,962 | 4 K to 34 K (+757.19 %) |
Jan 04 2016 | RLYP | Relypsa Inc | Stahl Wilhelm | SVP, Chief Technolo ... | Option Exercise | M | 3.96 | 3,709 | 14,688 | 46,597 | |
Jan 04 2016 | RLYP | Relypsa Inc | Stahl Wilhelm | SVP, Chief Technolo ... | Option Exercise | M | 3.96 | 16,291 | 64,512 | 27,759 | |
Jan 04 2016 | RLYP | Relypsa Inc | Stahl Wilhelm | SVP, Chief Technolo ... | Sell | S | 28.53 | 20,000 | 570,558 | 14,853 | 34.9 K to 14.9 K (-57.38 %) |
Jan 04 2016 | RLYP | Relypsa Inc | Stahl Wilhelm | SVP, Chief Technolo ... | Buy | M | 3.96 | 3,709 | 14,688 | 34,853 | 31.1 K to 34.9 K (+11.91 %) |
Jan 04 2016 | RLYP | Relypsa Inc | Stahl Wilhelm | SVP, Chief Technolo ... | Buy | M | 3.96 | 16,291 | 64,512 | 31,144 | 14.9 K to 31.1 K (+109.68 %) |
Dec 23 2015 | RLYP | Relypsa Inc | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 27.54 | 52,058 | 1,433,677 | 7,400,000 | 7.5 M to 7.4 M (-0.70 %) |
Dec 23 2015 | RLYP | Relypsa Inc | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 26.78 | 47,942 | 1,283,887 | 7,452,058 | 7.5 M to 7.5 M (-0.64 %) |
Dec 23 2015 | RLYP | Relypsa Inc | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 27.02 | 38,630 | 1,043,783 | 7,500,000 | 7.5 M to 7.5 M (-0.51 %) |
Dec 23 2015 | RLYP | Relypsa Inc | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 26.39 | 111,370 | 2,939,054 | 7,538,630 | 7.7 M to 7.5 M (-1.46 %) |
Dec 23 2015 | RLYP | Relypsa Inc | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 28.39 | 14,171 | 402,315 | 7,650,000 | 7.7 M to 7.7 M (-0.18 %) |
Dec 23 2015 | RLYP | Relypsa Inc | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 27.50 | 235,829 | 6,485,298 | 7,664,171 | 7.9 M to 7.7 M (-2.99 %) |
Dec 09 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Option Exercise | M | 7.40 | 10,000 | 74,000 | 727,877 | |
Dec 09 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Sell | S | 29.67 | 800 | 23,733 | 54,375 | 55.2 K to 54.4 K (-1.45 %) |
Dec 09 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Sell | S | 28.52 | 7,379 | 210,451 | 55,175 | 62.6 K to 55.2 K (-11.80 %) |
Dec 09 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Sell | S | 27.85 | 6,821 | 189,949 | 62,554 | 69.4 K to 62.6 K (-9.83 %) |
Dec 09 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Buy | M | 7.40 | 10,000 | 74,000 | 69,375 | 59.4 K to 69.4 K (+16.84 %) |
Dec 09 2015 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Option Exercise | M | 7.40 | 750 | 5,550 | 25,414 | |
Dec 09 2015 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Option Exercise | M | 7.40 | 4,755 | 35,187 | 26,164 | |
Dec 09 2015 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Option Exercise | M | 3.96 | 11,349 | 44,942 | 21,765 | |
Dec 09 2015 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Option Exercise | M | 3.96 | 13,896 | 55,028 | 10,668 | |
Dec 09 2015 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Sell | S | 29.50 | 750 | 22,125 | 21,290 | 22 K to 21.3 K (-3.40 %) |
Dec 09 2015 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Buy | M | 7.40 | 750 | 5,550 | 22,040 | 21.3 K to 22 K (+3.52 %) |
Dec 09 2015 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Sell | S | 29.78 | 30,000 | 893,400 | 21,290 | 51.3 K to 21.3 K (-58.49 %) |
Dec 09 2015 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Buy | M | 7.40 | 4,755 | 35,187 | 51,290 | 46.5 K to 51.3 K (+10.22 %) |
Dec 09 2015 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Buy | M | 3.96 | 11,349 | 44,942 | 46,535 | 35.2 K to 46.5 K (+32.25 %) |
Dec 09 2015 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Buy | M | 3.96 | 13,896 | 55,028 | 35,186 | 21.3 K to 35.2 K (+65.27 %) |
Dec 04 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Option Exercise | M | 7.40 | 20,000 | 148,000 | 737,877 | |
Dec 04 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Option Exercise | M | 7.40 | 20,000 | 148,000 | 757,877 | |
Dec 04 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Sell | S | 25.00 | 20,000 | 500,000 | 59,375 | 79.4 K to 59.4 K (-25.20 %) |
Dec 04 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Buy | M | 7.40 | 20,000 | 148,000 | 79,375 | 59.4 K to 79.4 K (+33.68 %) |
Dec 04 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Sell | S | 25.00 | 20,000 | 500,000 | 59,375 | 79.4 K to 59.4 K (-25.20 %) |
Dec 04 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Buy | M | 7.40 | 20,000 | 148,000 | 79,375 | 59.4 K to 79.4 K (+33.68 %) |
Nov 10 2015 | RLYP | Relypsa Inc | Krasnow Ronald A. | See Remarks | Grant | A | 0.00 | 4,375 | 0 | 14,853 | 10.5 K to 14.9 K (+41.75 %) |
Nov 10 2015 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Grant | A | 0.00 | 6,250 | 0 | 13,750 | 7.5 K to 13.8 K (+83.33 %) |
Nov 10 2015 | RLYP | Relypsa Inc | Harrison Stephen D | SVP & Chief Scienti ... | Grant | A | 0.00 | 6,250 | 0 | 13,750 | 7.5 K to 13.8 K (+83.33 %) |
Nov 10 2015 | RLYP | Relypsa Inc | Corbett Mary | Senior VP, Human Re ... | Grant | A | 0.00 | 4,375 | 0 | 14,853 | 10.5 K to 14.9 K (+41.75 %) |
Nov 10 2015 | RLYP | Relypsa Inc | Stahl Wilhelm | SVP, Chief Technolo ... | Grant | A | 0.00 | 4,375 | 0 | 14,853 | 10.5 K to 14.9 K (+41.75 %) |
Nov 10 2015 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Grant | A | 0.00 | 6,250 | 0 | 21,290 | 15 K to 21.3 K (+41.56 %) |
Nov 10 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Grant | A | 0.00 | 16,875 | 0 | 59,375 | 42.5 K to 59.4 K (+39.71 %) |
Nov 10 2015 | RLYP | Relypsa Inc | BALL KRISTINE M | Chief Financial Off ... | Grant | A | 0.00 | 6,250 | 0 | 21,290 | 15 K to 21.3 K (+41.56 %) |
Oct 22 2015 | RLYP | Relypsa Inc | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 12.92 | 310,700 | 4,014,244 | 7,900,000 | 7.6 M to 7.9 M (+4.09 %) |
Oct 22 2015 | RLYP | Relypsa Inc | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 11.97 | 189,300 | 2,265,921 | 7,589,300 | 7.4 M to 7.6 M (+2.56 %) |
Sep 03 2015 | RLYP | Relypsa Inc | BALL KRISTINE M | Chief Financial Off ... | Sell | S | 22.96 | 646 | 14,832 | 15,040 | 15.7 K to 15 K (-4.12 %) |
Aug 19 2015 | RLYP | Relypsa Inc | Krasnow Ronald A. | See Remarks | Sell | S | 24.75 | 522 | 12,922 | 10,478 | 11 K to 10.5 K (-4.75 %) |
Aug 19 2015 | RLYP | Relypsa Inc | Corbett Mary | Senior VP, Human Re ... | Sell | S | 24.72 | 1 | 25 | 10,478 | 10.5 K to 10.5 K (-0.01 %) |
Aug 19 2015 | RLYP | Relypsa Inc | Corbett Mary | Senior VP, Human Re ... | Sell | S | 24.72 | 521 | 12,881 | 10,479 | 11 K to 10.5 K (-4.74 %) |
Aug 19 2015 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Sell | S | 24.77 | 710 | 17,586 | 15,040 | 15.8 K to 15 K (-4.51 %) |
Aug 19 2015 | RLYP | Relypsa Inc | BALL KRISTINE M | Chief Financial Off ... | Sell | S | 24.78 | 710 | 17,597 | 15,040 | 15.8 K to 15 K (-4.51 %) |
Aug 19 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Sell | S | 25.00 | 2,366 | 59,150 | 42,500 | 44.9 K to 42.5 K (-5.27 %) |
Aug 19 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Sell | S | 24.69 | 2,634 | 65,033 | 44,866 | 47.5 K to 44.9 K (-5.55 %) |
Aug 19 2015 | RLYP | Relypsa Inc | Stahl Wilhelm | SVP, Chief Technolo ... | Sell | S | 24.70 | 522 | 12,894 | 10,478 | 11 K to 10.5 K (-4.75 %) |
Aug 19 2015 | RLYP | Relypsa Inc | Lockey Claire | See Remarks | Sell | S | 24.69 | 522 | 12,888 | 10,478 | 11 K to 10.5 K (-4.75 %) |
Aug 12 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Option Exercise | A | 28.38 | 105,000 | 2,979,900 | 105,000 | |
Aug 12 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Grant | A | 0.00 | 22,500 | 0 | 47,500 | 25 K to 47.5 K (+90.00 %) |
Aug 12 2015 | RLYP | Relypsa Inc | Lockey Claire | See Remarks | Option Exercise | A | 28.38 | 24,500 | 695,310 | 24,500 | |
Aug 12 2015 | RLYP | Relypsa Inc | Lockey Claire | See Remarks | Grant | A | 0.00 | 5,500 | 0 | 11,000 | 5.5 K to 11 K (+100.00 %) |
Aug 12 2015 | RLYP | Relypsa Inc | Krasnow Ronald A. | See Remarks | Option Exercise | A | 28.38 | 24,500 | 695,310 | 24,500 | |
Aug 12 2015 | RLYP | Relypsa Inc | Krasnow Ronald A. | See Remarks | Grant | A | 0.00 | 5,500 | 0 | 11,000 | 5.5 K to 11 K (+100.00 %) |
Aug 12 2015 | RLYP | Relypsa Inc | Harrison Stephen D | SVP & Chief Scienti ... | Option Exercise | A | 28.38 | 35,000 | 993,300 | 35,000 | |
Aug 12 2015 | RLYP | Relypsa Inc | Harrison Stephen D | SVP & Chief Scienti ... | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
Aug 12 2015 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Option Exercise | A | 28.38 | 35,000 | 993,300 | 35,000 | |
Aug 12 2015 | RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commerc ... | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
Aug 12 2015 | RLYP | Relypsa Inc | Corbett Mary | SVP, Human Resource ... | Option Exercise | A | 28.38 | 24,500 | 695,310 | 24,500 | |
Aug 12 2015 | RLYP | Relypsa Inc | Corbett Mary | SVP, Human Resource ... | Grant | A | 0.00 | 5,500 | 0 | 11,000 | 5.5 K to 11 K (+100.00 %) |
Aug 12 2015 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Option Exercise | A | 28.38 | 38,500 | 1,092,630 | 38,500 | |
Aug 12 2015 | RLYP | Relypsa Inc | Berman Lance | Chief Medical Offic ... | Grant | A | 0.00 | 8,250 | 0 | 15,750 | 7.5 K to 15.8 K (+110.00 %) |
Aug 12 2015 | RLYP | Relypsa Inc | BALL KRISTINE M | Chief Financial Off ... | Option Exercise | A | 28.38 | 38,500 | 1,092,630 | 38,500 | |
Aug 12 2015 | RLYP | Relypsa Inc | BALL KRISTINE M | Chief Financial Off ... | Grant | A | 0.00 | 8,250 | 0 | 15,750 | 7.5 K to 15.8 K (+110.00 %) |
Aug 12 2015 | RLYP | Relypsa Inc | Stahl Wilhelm | SVP, Chief Technolo ... | Option Exercise | A | 28.38 | 24,500 | 695,310 | 24,500 | |
Aug 12 2015 | RLYP | Relypsa Inc | Stahl Wilhelm | SVP, Chief Technolo ... | Grant | A | 0.00 | 5,500 | 0 | 11,000 | 5.5 K to 11 K (+100.00 %) |
Aug 03 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Option Exercise | M | 7.40 | 5,000 | 37,000 | 777,877 | |
Aug 03 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Option Exercise | M | 7.40 | 20,000 | 148,000 | 782,877 | |
Aug 03 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Sell | S | 34.14 | 200 | 6,828 | 25,000 | 25.2 K to 25 K (-0.79 %) |
Aug 03 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Sell | S | 33.51 | 9,800 | 328,397 | 25,200 | 35 K to 25.2 K (-28.00 %) |
Aug 03 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Buy | M | 7.40 | 5,000 | 37,000 | 35,000 | 30 K to 35 K (+16.67 %) |
Aug 03 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Sell | S | 34.11 | 200 | 6,822 | 30,000 | 30.2 K to 30 K (-0.66 %) |
Aug 03 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Sell | S | 33.57 | 19,800 | 664,751 | 30,200 | 50 K to 30.2 K (-39.60 %) |
Aug 03 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Buy | M | 7.40 | 20,000 | 148,000 | 50,000 | 30 K to 50 K (+66.67 %) |
Jun 15 2015 | RLYP | Relypsa Inc | MCGIRR DAVID W J | Director | Sell | S | 34.67 | 1,220 | 42,300 | 3,742 | 5 K to 3.7 K (-24.59 %) |
Jun 15 2015 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Sell | S | 34.63 | 1,454 | 50,359 | 3,508 | 5 K to 3.5 K (-29.30 %) |
Jun 15 2015 | RLYP | Relypsa Inc | Butler John P. | Director | Sell | S | 34.62 | 1,100 | 38,087 | 3,862 | 5 K to 3.9 K (-22.17 %) |
Jun 15 2015 | RLYP | Relypsa Inc | Schuetz Thomas J. | Director | Sell | S | 34.57 | 1,000 | 34,571 | 3,962 | 5 K to 4 K (-20.15 %) |
Jun 09 2015 | RLYP | Relypsa Inc | MCGIRR DAVID W J | Director | Option Exercise | A | 35.79 | 4,500 | 161,055 | 4,500 | |
Jun 09 2015 | RLYP | Relypsa Inc | MCGIRR DAVID W J | Director | Grant | A | 0.00 | 2,250 | 0 | 4,962 | 2.7 K to 5 K (+82.96 %) |
Jun 08 2015 | RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Option Exercise | A | 35.79 | 4,500 | 161,055 | 4,500 | |
Jun 08 2015 | RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Grant | A | 0.00 | 2,250 | 0 | 2,250 | 0 to 2.3 K |
Jun 08 2015 | RLYP | Relypsa Inc | Hillan Kenneth J. | Director | Option Exercise | A | 35.79 | 4,500 | 161,055 | 4,500 | |
Jun 08 2015 | RLYP | Relypsa Inc | Hillan Kenneth J. | Director | Grant | A | 0.00 | 2,250 | 0 | 2,250 | 0 to 2.3 K |
Jun 08 2015 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Option Exercise | A | 35.79 | 4,500 | 161,055 | 4,500 | |
Jun 08 2015 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Grant | A | 0.00 | 2,250 | 0 | 4,962 | 2.7 K to 5 K (+82.96 %) |
Jun 08 2015 | RLYP | Relypsa Inc | Butler John P. | Director | Option Exercise | A | 35.79 | 4,500 | 161,055 | 4,500 | |
Jun 08 2015 | RLYP | Relypsa Inc | Butler John P. | Director | Grant | A | 0.00 | 2,250 | 0 | 4,962 | 2.7 K to 5 K (+82.96 %) |
Jun 08 2015 | RLYP | Relypsa Inc | Schuetz Thomas J. | Director | Option Exercise | A | 35.79 | 4,500 | 161,055 | 4,500 | |
Jun 08 2015 | RLYP | Relypsa Inc | Schuetz Thomas J. | Director | Grant | A | 0.00 | 2,250 | 0 | 4,962 | 2.7 K to 5 K (+82.96 %) |
Jun 08 2015 | RLYP | Relypsa Inc | Torley Helen | Director | Option Exercise | A | 35.79 | 4,500 | 161,055 | 4,500 | |
Jun 08 2015 | RLYP | Relypsa Inc | Torley Helen | Director | Grant | A | 0.00 | 2,250 | 0 | 2,250 | 0 to 2.3 K |
Jun 02 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Option Exercise | M | 7.40 | 8,555 | 63,307 | 802,877 | |
Jun 02 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Option Exercise | M | 7.40 | 20,000 | 148,000 | 811,432 | |
Jun 02 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Sell | S | 36.94 | 5,204 | 192,255 | 30,000 | 35.2 K to 30 K (-14.78 %) |
Jun 02 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Sell | S | 35.79 | 8,351 | 298,893 | 35,204 | 43.6 K to 35.2 K (-19.17 %) |
Jun 02 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Buy | M | 7.40 | 8,555 | 63,307 | 43,555 | 35 K to 43.6 K (+24.44 %) |
Jun 02 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Sell | S | 36.98 | 5,306 | 196,208 | 35,000 | 40.3 K to 35 K (-13.16 %) |
Jun 02 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Sell | S | 36.40 | 14,694 | 534,793 | 40,306 | 55 K to 40.3 K (-26.72 %) |
Jun 02 2015 | RLYP | Relypsa Inc | Orwin John A | President & CEO | Buy | M | 7.40 | 20,000 | 148,000 | 55,000 | 35 K to 55 K (+57.14 %) |
May 20 2015 | RLYP | Relypsa Inc | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 34.13 | 1,457,551 | 49,746,216 | 7,400,000 | 8.9 M to 7.4 M (-16.46 %) |
May 13 2015 | RLYP | Relypsa Inc | VEITINGER KLAUS R DR | Director | Option Exercise | M | 3.96 | 5,834 | 23,103 | 69,543 | |
May 13 2015 | RLYP | Relypsa Inc | VEITINGER KLAUS R DR | Director | Sell | S | 36.06 | 5,834 | 210,387 | 2,712 | 8.5 K to 2.7 K (-68.27 %) |
May 13 2015 | RLYP | Relypsa Inc | VEITINGER KLAUS R DR | Director | Buy | M | 3.96 | 5,834 | 23,103 | 8,546 | 2.7 K to 8.5 K (+215.12 %) |
Apr 13 2015 | RLYP | Relypsa Inc | VEITINGER KLAUS R DR | Director | Option Exercise | M | 3.96 | 5,832 | 23,095 | 75,377 | |
Apr 13 2015 | RLYP | Relypsa Inc | VEITINGER KLAUS R DR | Director | Sell | S | 35.35 | 5,832 | 206,179 | 2,712 | 8.5 K to 2.7 K (-68.26 %) |
Apr 13 2015 | RLYP | Relypsa Inc | VEITINGER KLAUS R DR | Director | Buy | M | 3.96 | 5,832 | 23,095 | 8,544 | 2.7 K to 8.5 K (+215.04 %) |
Mar 12 2015 | RLYP | Relypsa Inc | VEITINGER KLAUS R DR | Director | Option Exercise | M | 3.96 | 2,503 | 9,912 | 81,209 | |
Mar 12 2015 | RLYP | Relypsa Inc | VEITINGER KLAUS R DR | Director | Option Exercise | M | 4.65 | 3,331 | 15,489 | 12,795 |